These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 2170505

  • 21. [Identification and antifungal susceptibility of Candida spp isolated from invasive mycoses. Influence of growth inhibition percentage to determine minimal inhibitory concentration].
    Alvarado D, Díaz MC, Silva V.
    Rev Med Chil; 2002 Apr; 130(4):416-23. PubMed ID: 12090107
    [Abstract] [Full Text] [Related]

  • 22. [Activity of itraconazole against clinical isolates of Aspergillus spp. and Fusarium spp. determined by the M38-P NCCLS method].
    Carrillo-Muñoz AJ, Quindós G, Ruesga M, Brió S, del Valle O, Rodríguez V, Hernández-Molina JM, Cantón E, Pemán J, Santos P.
    Rev Esp Quimioter; 2001 Sep; 14(3):281-5. PubMed ID: 11753450
    [Abstract] [Full Text] [Related]

  • 23. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
    Brooks DE, Andrew SE, Dillavou CL, Ellis G, Kubilis PS.
    Am J Vet Res; 1998 Feb; 59(2):138-42. PubMed ID: 9492925
    [Abstract] [Full Text] [Related]

  • 24. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
    Mondello F, De Bernardis F, Girolamo A, Salvatore G, Cassone A.
    J Antimicrob Chemother; 2003 May; 51(5):1223-9. PubMed ID: 12668571
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S.
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [In vitro antifungal activity of itraconazole: a comparative study with ketoconazole].
    Hiratani T, Yamaguchi H.
    Jpn J Antibiot; 1991 May; 44(5):580-7. PubMed ID: 1652656
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antifungal activities and cytotoxicity studies of six new azasordarins.
    Herreros E, Almela MJ, Lozano S, Gomez de las Heras F, Gargallo-Viola D.
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3132-9. PubMed ID: 11600368
    [Abstract] [Full Text] [Related]

  • 31. Itraconazole vs amphotericin B: in vitro comparative evaluation of the minimal inhibitory concentration (MIC) against clinically isolated yeasts.
    Lombardi G, Gramegna G, Cavanna C, Poma G, Marangoni E, Michelone G.
    Mycopathologia; 1989 Apr; 106(1):31-4. PubMed ID: 2549421
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effects of culture media on the in vitro susceptibility of selected opportunistic fungi to fluconazole and itraconazole.
    Sekhon AS, Padhye AA, Garg AK, Hamir Z.
    Chemotherapy; 1992 Apr; 38(3):169-73. PubMed ID: 1324830
    [Abstract] [Full Text] [Related]

  • 34. Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.
    Arzeni D, Barchiesi F, Ancarani F, Scalise G.
    J Chemother; 1991 Jun; 3(3):139-42. PubMed ID: 1655990
    [Abstract] [Full Text] [Related]

  • 35. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses].
    Uchida K, Hosaka J, Aoki K, Yamaguchi H.
    Jpn J Antibiot; 1991 May; 44(5):571-9. PubMed ID: 1652655
    [Abstract] [Full Text] [Related]

  • 36. In vitro susceptibility studies with oxiconazole (Ro 13-8996).
    Gebhart RJ, Espinel-Ingroff A, Shadomy S.
    Chemotherapy; 1984 May; 30(4):244-7. PubMed ID: 6086246
    [Abstract] [Full Text] [Related]

  • 37. In vitro studies with R 51,211 (itraconazole).
    Espinel-Ingroff A, Shadomy S, Gebhart RJ.
    Antimicrob Agents Chemother; 1984 Jul; 26(1):5-9. PubMed ID: 6089654
    [Abstract] [Full Text] [Related]

  • 38. Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models.
    Van Cutsem J, Van Gerven F, Janssen PA.
    Rev Infect Dis; 1987 Jul; 9 Suppl 1():S15-32. PubMed ID: 3027843
    [Abstract] [Full Text] [Related]

  • 39. In vitro susceptibilities of zygomycetes to conventional and new antifungals.
    Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE, Eurofung Network.
    J Antimicrob Chemother; 2003 Jan; 51(1):45-52. PubMed ID: 12493786
    [Abstract] [Full Text] [Related]

  • 40. Antimycotic susceptibility testing of agents of black grain eumycetoma.
    Venugopal PV, Venugopal TV, Ramakrishna ES, Ilavarasi S.
    J Med Vet Mycol; 1993 Jan; 31(2):161-4. PubMed ID: 8389847
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.